abstract |
The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to a pneumococcal polysaccharide conjugate having the specific advantage that 3D-MPL is added as an adjuvant and substantially free of an aluminum-based adjuvant. |